Advertisement

SciSparc Ltd. SPRC

Set alert

Price alert · SPRC

All alert types
0.68 USD -0.04 -5.05%

At close · Oct 30

0.65 -0.03 -3.87%

After hours · Oct 30, 7:48 PM ET

Bid
0.66 × 1
Ask
0.67 × 1
0.6031 Day range 0.6843
0.6763 52-week range 29.88
YTD
-94.47%
1 year
-97.69%
Open
0.6769
Prev close
0.7123
Mkt cap
392.91K
Vol
378.10K
Avg vol
1.34M
EPS
248.24
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6031
High
0.6843
Forward P/E
0.00
Beta
1.04
Short ratio
0.22
Inst. own
1.73%
Dividend
0.00
Ex-div date
50-d avg
0.23526
200-d avg
0.77116
1y target
0.00

MAX chart

Chart tools
Interval

Events in this range
  • Sep 28, 2023Split: 1 for 26
  • Jul 3, 2025Split: 1 for 21
  • Mar 4, 2026Split: 1 for 9
Signals (66)
NameDateAgo
MACD: Sell SignalOct 19, 20261 week ago
SMA: BearishAug 31, 20262 months ago
SMA: BearishAug 31, 20262 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BullishApr 20, 20266 months ago
RSI: OversoldJan 26, 20269 months ago
MACD: Buy SignalJan 19, 20269 months ago
MACD: Sell SignalNov 17, 202511 months ago
SMA: BearishOct 27, 20251 year ago
SMA: BullishSep 29, 20251 year ago
MACD: Buy SignalSep 29, 20251 year ago
SMA: BearishSep 22, 20251 year ago
SMA: BullishSep 15, 20251 year ago
MACD: Sell SignalAug 25, 20251 year ago
RSI: OversoldAug 25, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BearishJun 16, 20251 year ago
SMA: BullishMay 5, 20251 year ago
SMA: BearishMar 17, 20251 year ago
SMA: BullishMar 10, 20251 year ago
SMA: BearishMar 3, 20251 year ago
SMA: BearishFeb 17, 20251 year ago
SMA: BullishDec 23, 20241 year ago
SMA: BullishDec 23, 20241 year ago
SMA: BearishDec 16, 20241 year ago
SMA: BullishDec 2, 20241 year ago
SMA: BearishNov 25, 20241 year ago
SMA: BullishNov 18, 20241 year ago
RSI: OversoldJul 22, 20242 years ago
SMA: BearishNov 27, 20232 years ago
SMA: BullishNov 20, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BearishOct 23, 20233 years ago
SMA: BullishOct 16, 20233 years ago
MACD: Buy SignalOct 16, 20233 years ago
MACD: Sell SignalAug 7, 20233 years ago
RSI: OversoldAug 7, 20233 years ago
SMA: BearishJun 26, 20233 years ago
SMA: BullishJun 19, 20233 years ago
SMA: BearishJun 5, 20233 years ago
SMA: BullishApr 24, 20233 years ago
SMA: BearishFeb 27, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BullishFeb 13, 20233 years ago
SMA: BullishFeb 13, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
SMA: BullishJan 30, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishDec 5, 20223 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BearishOct 17, 20224 years ago
SMA: BullishOct 3, 20224 years ago
MACD: Buy SignalSep 12, 20224 years ago
RSI: OversoldAug 8, 20224 years ago
SMA: BearishJun 6, 20224 years ago
SMA: BullishMay 30, 20224 years ago
RSI: OversoldMar 7, 20224 years ago
SMA: BearishDec 20, 20214 years ago

Key statistics

Market cap
2.41M
Enterprise value
4.92K
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
1.38
Price / book
0.12
EPS (TTM)
-5.28
Beta
1.04
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
1.75M
Revenue growth
-57.40%
Free cash flow
-3.97M
Total cash
2.56M
Total debt
64.00K
Return on equity
-85.91%
Shares outstanding
10.36M
Short % of float
0.93%
50-day average
0.23526
200-day average
0.77116

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
SPRC Revenue — quarterly 0
2018-Q4 2018
SPRC Net income — quarterly -4.37M
2018-Q4 2018
SPRC EPS — quarterly 1,375,920.00
2018-Q4 2018

About SciSparc Ltd.

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel
Website
scisparc.com

News

Your note

Sign in to keep a note on SPRC — it syncs with the Stock Master app.

Institution ownership

SPRC institution ownership
Holder% heldSharesValueReported
UBS Group AG0.67%69,00616.06KSep 29, 2024
Two Sigma Securities, LLC0.36%37,0828.63KSep 29, 2024
Virtu Financial LLC0.14%14,1063.28KSep 29, 2024
Rhumbline Advisers0.03%3,464806Sep 29, 2024
Morgan Stanley0.00%23855Sep 29, 2024
Advertisement